Safety of treatment options for spondyloarthritis: a narrative review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of treatment options for spondyloarthritis: a narrative review
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 17, Issue 5, Pages 475-486
Publisher
Informa UK Limited
Online
2018-03-06
DOI
10.1080/14740338.2018.1448785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study
- (2017) Arthur Kavanaugh et al. ARTHRITIS CARE & RESEARCH
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
- (2016) Karin Hellgren et al. ANNALS OF THE RHEUMATIC DISEASES
- The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review
- (2016) Cecilia Beatrice Chighizola et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Secukinumab: A Review in Ankylosing Spondylitis
- (2016) Hannah A. Blair et al. DRUGS
- Improvements in diagnostic tools for early detection of psoriatic arthritis
- (2016) Salvatore D’Angelo et al. Expert Review of Clinical Immunology
- Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on “Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study” by Tseng et al., Joint Bone Spine 2016;83:307–13
- (2016) Francesco Ursini et al. JOINT BONE SPINE
- Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study
- (2016) L. Costa et al. JOURNAL OF RHEUMATOLOGY
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
- (2016) Peter C.M. van de Kerkhof et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Advancement continues in imaging, tight control and new drugs
- (2016) Ignazio Olivieri et al. Nature Reviews Rheumatology
- Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
- (2016) Laure Gossec et al. Nature Reviews Rheumatology
- Ankylosing Spondylitis and Axial Spondyloarthritis
- (2016) Joel D. Taurog et al. NEW ENGLAND JOURNAL OF MEDICINE
- A meta-analysis of apremilast on psoriatic arthritis long-term assessment of clinical efficacy (PALACE)
- (2016) Xiaoyu Qu et al. Expert Review of Clinical Pharmacology
- Secukinumab for ankylosing spondylitis and psoriatic arthritis
- (2016) Ennio Lubrano et al. Therapeutics and Clinical Risk Management
- Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality
- (2015) Nisha Nigil Haroon et al. ANNALS OF INTERNAL MEDICINE
- European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
- (2015) L Gossec et al. ANNALS OF THE RHEUMATIC DISEASES
- Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses
- (2015) Yuehong Chen et al. CLINICAL RHEUMATOLOGY
- Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
- (2015) Alice Capogrosso Sansone et al. DRUG SAFETY
- Drug safety evaluation of apremilast for treating psoriatic arthritis
- (2015) Swapna Busa et al. Expert Opinion On Drug Safety
- Pharmacological therapy of spondyloarthritis
- (2015) Carlo Palazzi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study
- (2015) L. E. Kristensen et al. ARTHRITIS CARE & RESEARCH
- Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial
- (2015) Arthur Kavanaugh et al. ARTHRITIS CARE & RESEARCH
- Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis: Results from a Phase III Randomized Trial
- (2015) J. Sieper et al. Arthritis & Rheumatology
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
- (2014) Atul Deodhar et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Advances in the management of psoriatic arthritis
- (2014) Ignazio Olivieri et al. Nature Reviews Rheumatology
- Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
- (2014) Lívia Lovato Pires Lemos et al. RHEUMATOLOGY INTERNATIONAL
- Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study
- (2014) Delia Colombo et al. Biomed Research International
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of anti-tumor necrosis factor agents in psoriatic arthritis – an update
- (2013) Carlo Palazzi et al. Expert Opinion On Drug Safety
- Paradoxical effects of anti-TNF-α agents in inflammatory diseases
- (2013) Daniel Wendling et al. Expert Review of Clinical Immunology
- Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis
- (2013) S. Fénix-Caballero et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Spondyloarthritis with Onset After Age 45
- (2013) Ignazio Olivieri et al. Current Rheumatology Reports
- Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden early arthritis cohort
- (2012) Rosaline van den Berg et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
- (2012) Ejaz Pathan et al. ANNALS OF THE RHEUMATIC DISEASES
- Therapeutic Controversies in Spondyloarthritis
- (2012) Denis Poddubnyy et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
- (2012) Gabrielle H. Kingsley et al. RHEUMATOLOGY
- Leflunomide in psoriatic arthritis: Results from a large European prospective observational study
- (2012) Frank Behrens et al. ARTHRITIS CARE & RESEARCH
- Increased mortality in ankylosing spondylitis is related to disease activity
- (2011) G. Bakland et al. ANNALS OF THE RHEUMATIC DISEASES
- Spondyloarthritis
- (2011) Maxime Dougados et al. LANCET
- The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
- (2010) M. Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Local effects of intra-articular corticosteroids
- (2010) George S. Habib et al. CLINICAL RHEUMATOLOGY
- Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis
- (2009) E. Lie et al. ANNALS OF THE RHEUMATIC DISEASES
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
- (2009) M Rudwaleit et al. ANNALS OF THE RHEUMATIC DISEASES
- Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
- (2009) J R Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis
- (2009) S. D'Angelo et al. ANNALS OF THE RHEUMATIC DISEASES
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs
- (2008) I. H. Song et al. ARTHRITIS AND RHEUMATISM
- Role of Trauma in Psoriatic Arthritis
- (2008) Ignazio Olivieri et al. JOURNAL OF RHEUMATOLOGY
- A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
- (2007) V Ravindran et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now